A new strategy for the green synthesis of chondroitin sulfate-reduced gold nanoparticles; in vitro evaluation of synthesized nanoparticles.
Conclusion: The results indicate the advantages of using CHS to produce blood-compatible GNPs with antioxidant, cytotoxic, and electrochemical properties.
PMID: 32983937 [PubMed]
Source: BioImpacts - Category: Research Tags: Bioimpacts Source Type: research
More News: Antidoxidants | Cancer | Cancer & Oncology | Nanotechnology | Research | Study | Thrombosis